Site Search

AUGUSTA, ME – JANUARY 29, 2024 – On Tuesday, January 30, Maine’s Joint Standing Committee on Health Coverage, Insurance and Financial Services will consider LD 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges ... support the bill, which aims to expand coverage for biomarker testing—when medically appropriate—to Mainers insured through state-regulated health plans, including Medicaid.   Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. It has become a game-changing part of cancer care by opening the door to targeted treatments that can lead to improved survivorship and quality of life. Despite the proven benefits and ...

... breakthroughs in research and treatment, but there is still a lot of work to be done. If New York aims to remain a national leader in cancer care, as I believe the Empire State is meant to be, our elected officials must be champions in the fight to achieve health equity for all communities. From the inception of Medicare to the expansion of Medicaid, health equity has been the throughline for policies that improve health outcomes and address morbidity and mortality rates. There is plenty of ...

... Shapiro signed House Bill 1754 into law, securing a major win for patients across Pennsylvania. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable more Pennsylvanians to access biomarker testing that ... for the American Cancer Society Cancer Action Network (ACS CAN) in Pennsylvania. “This game-changing bill is good for Pennsylvania—the health of our state and its residents. Ensuring that more Pennsylvanians will have access to proven biomarker testing will mean more patients ... on this critical legislation and Governor Shapiro for signing it into law." Biomarker testing has become a game-changing part of cancer care given its role in opening the door to personalized care, including targeted treatments that can lead to improved survivorship and quality of ...

SACRAMENTO , Calif. – California Governor Gavin Newsom announced he has signed Senate Bill 496 on Saturday, ensuring that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence. The bill, ... Newsom for taking this crucial step to turn the promise of precision medicine into a reality for more Californians. A longstanding leader in health equity and medical innovation, California joins twelve other states that have enacted similar legislation,” said Dr. Karen E. Knudsen, CEO ... that often improve survivorship and quality of life for cancer patients and others with chronic diseases. “Biomarker testing can help health care providers render the right treatment at the right time and is increasingly important for cancer care and the treatment of diseases like ...